Zydus gets USFDA's final nod to market antifungal Micafungin for injection

Oct 26, 2022

Zydus Lifesciences has received approval from US Food and Drug Administration to market Micafungin.

Zydus Reports 97 per cent Growth in Net Profit in FY24

May 18, 2024

Ahmedabad (Gujarat) [India], May 18: Zydus Lifesciences Limited announces Q4 and FY24 financial performance. Summary:

Zydus Lifesciences gets DCGI approval for Oxemia drug

Mar 07, 2022

Ahmedabad (Gujarat) [India], March 7 : Zydus Lifesciences on Monday said it has received approval from the Drug Controller General of India (DCGI) for...

Zydus Lifesciences Q2 Net Profit up by 53% Y-o-Y

Nov 07, 2023

Ahmedabad (Gujarat) [India], November 7: Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and half year ended September 30th, 2023.

Zydus Lifesciences Limited Reports Strong Operating Performance in Q1FY24

Aug 11, 2023

Ahmedabad (Gujarat) [India], August 11: Zydus Lifesciences Limited (including its subsidiaries/ affiliates hereafter referred to as “Zydus”) announced its Q1FY24 results today. Zydus posts...

DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children above 12

Apr 26, 2022

Ahmedabad (Gujarat) [India], April 26 : The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine...